Related Experiment Video
Updated: Jun 26, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
A novel function for dendritic cell: clearance of VEGF via VEGF receptor-1
Yi Xie1, Jianqing Fan, Juhua Chen
1Department of Surgery, The University of Hong Kong, Hong Kong SAR, China.
Abstract:
It has been reported that the plasma levels of VEGF in tumor patients decreased during dendritic cell (DC)-based immunotherapy, but the underlying mechanism remains unclear. Our current report demonstrates that VEGF levels were significantly decreased in the supernatants of DCs incubated with rhVEGF or tumor conditioned medium (TCM) while the intracellular VEGF in DCs was increased. The increased intracellular VEGF was not due to the de novo VEGF synthesis by DCs because exogenous VEGF inhibited the mRNA expression of VEGF in DCs. More direct evidence was provided to demonstrate that Cy3-labeled VEGF could be internalized by DCs specifically and efficiently. In addition, the activity of DCs to internalize VEGF was abolished by neutralizing antibody against VEGF receptor-1 (Flt-1) and inhibitors of endocytosis such as carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and genistein. This study highlights a novel function of DCs and allows a better understanding of the DC-VEGF interaction.
Insights
Dendritic cells (DCs) internalize vascular endothelial growth factor (VEGF) during immunotherapy, reducing its levels outside the cell. This novel DC function clarifies the mechanism behind VEGF decrease in cancer patients undergoing DC-based treatments.
Area of Science:
- Immunology
- Cancer Biology
- Cell Biology
Background:
- Plasma levels of vascular endothelial growth factor (VEGF) decrease during dendritic cell (DC)-based immunotherapy in tumor patients.
- The underlying mechanism for this VEGF reduction remains unclear.
Purpose of the Study:
- To investigate the interaction between dendritic cells (DCs) and VEGF.
- To elucidate the mechanism by which DCs affect VEGF levels during immunotherapy.
Main Methods:
- Incubation of DCs with recombinant human VEGF (rhVEGF) or tumor-conditioned medium (TCM).
- Measurement of intracellular and supernatant VEGF levels.
- Assessment of VEGF mRNA expression in DCs.
- Tracking of Cy3-labeled VEGF internalization by DCs.
- Inhibition studies using anti-VEGF receptor-1 (Flt-1) antibodies and endocytosis inhibitors (CCCP, genistein).
Main Results:
- VEGF levels decreased in DC supernatants, while intracellular VEGF increased.
- Exogenous VEGF suppressed endogenous VEGF mRNA expression in DCs, indicating it's not de novo synthesis.
- DCs efficiently and specifically internalized exogenous VEGF.
- VEGF internalization by DCs was inhibited by anti-Flt-1 antibodies and endocytosis inhibitors.
Conclusions:
- Dendritic cells possess a novel function of actively internalizing VEGF.
- This internalization mechanism, dependent on VEGF receptor-1 and endocytosis, contributes to the observed decrease in plasma VEGF levels during DC-based immunotherapy.
- Understanding this DC-VEGF interaction provides insights into immunotherapy efficacy.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mechanism of Angiogenesis
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

